Firdapse and Ruzurgi (Amifampridine)

Firdapse (amifampridine) is the first LEMS-specific treatment approved by the FDA in the U.S. for patients 17 and older. Ruzurgi (amifampridine) is the first treatment for patients ages 6 to 16. Join this forum to discuss the ins...
View more

Lambert-Eaton News Forums Forums Treating LEMS Firdapse and Ruzurgi (Amifampridine)

Viewing 1 - 24 of 43 discussions

You must be logged in to create new discussions.